BB-11

N/A

Report date: 2026/01/29 16:01:02

Base Information

Drug NameBB-11

Drug Alias Namesilicon-based tunable drug conjugates (BlinkBio/The Scripps Research Institute/Genomics Institute of the Novartis Research Foundation)folate receptor alpha-tunable drug conjugates utlizing silicon-based linkers and payload cassettes (BlinkBio)BB-01 (BlinkBio)BB-03 (BlinkBio)BB-42 (BlinkBio) +[10]

ClassificationSmall moleculesBiologics > Protein drugs > Toxin

Mechanisms of ActionFolate receptor alpha modulators

TargetsFolate receptor alpha

Therapy Area/IndicationsSolid tumoursOvarian NeoplasmsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesBlinkBio Inc

China Registration ClassN/A

Develop Information

Active CompaniesBlinkBio Inc

Inactive CompaniesN/A

Active IndicationsSolid tumoursOvarian Neoplasms

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A